x

Faculty Profile

Philip J. Santangelo
Professor, Jonathan and Sheryl Layne Professor of Biomedical Engineering, Emory Vaccine Center , Winship Cancer Institute
Email
HSRBII N542
678-227-4660
Santangelo Lab
Research Interests:

mRNA-based therapeutics and vaccines; optical and PET/CT imaging techniques

Publications:

  

  

     

  

Videos:

 

 

Latest Articles:
Phil Santangelo led a research team that's developed a new mRNA and CRISPR based treatment for dengue virus.
mRNA and Gene Editing Tools Offer New Hope for Dengue Virus Treatment

From left, Lorena Chaves, Jose Assumpcao, and Philip Santangelo are standing in a lab examining mRNA samples.
BME Researchers Lead $24M Project Using mRNA to ‘Turn On’ Helpful Immune Responses

Philip Santangelo wants to build a toolbox of mRNA drugs to activate or shut off specific genes to help the immune system fight cancer and other disorders.

nebulizer
Healing Breath: Researchers Dramatically Improve Inhalable mRNA Therapy

Digital illustration of RNA / DNA strands. (iStock)
Researchers Successfully Use mRNA to Activate Genes

Dahlman and Santangelo
New System Speeds Screening of Drug-Delivering Nanoparticles

‘Species agnostic’ screening is the latest result of a powerful partnership between James Dahlman and Phil Santangelo